New York-based Pfizer Inc. (PFE) is a global pharmaceutical and biotechnology company that develops, manufactures, and commercializes medicines and vaccines across oncology, cardiovascular disease, immunology, and infectious diseases. Its major products include Eliquis, Prevnar, Paxlovid, and the Comirnaty COVID-19 vaccine. PFE currently has a market cap of $167.9 billion.
Shares of this pharmaceutical giant have outperformed the broader market over the past year. PFE has gained 23.3% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 12%. Moreover, over the past six months, PFE stock is up 14.1%, surpassing SPX’s 8.2% rise on a YTD basis.